These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33868667)

  • 21. Association of polymorphisms in GCKR and TRIB1 with nonalcoholic fatty liver disease and metabolic syndrome traits.
    Kitamoto A; Kitamoto T; Nakamura T; Ogawa Y; Yoneda M; Hyogo H; Ochi H; Mizusawa S; Ueno T; Nakao K; Sekine A; Chayama K; Nakajima A; Hotta K
    Endocr J; 2014; 61(7):683-9. PubMed ID: 24785259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathological Profile and Outcome of a Large Cohort of Patients with Nonalcoholic Fatty Liver Disease from South Asia: Interim Results of the Indian Consortium on Nonalcoholic Fatty Liver Disease.
    Duseja A; Singh SP; Mehta M; Shalimar ; Venkataraman J; Mehta V; Devadas K; Kar SK; Goyal O; Nagral A; Saigal S; Nijhawan S; Praharaj D; Shukla A; Sharma B; Narayanasamy K; Kumar P; Rao PN; Arora A; Mehta R; Asati P; Ranjan P; Koshy A; Alam S; Mukewar S; Mukewar S; Mohan Prasad VG; Rastogi M; Sanyal AJ
    Metab Syndr Relat Disord; 2022 Apr; 20(3):166-173. PubMed ID: 35085026
    [No Abstract]   [Full Text] [Related]  

  • 23. The Role Bariatric Surgery and Endobariatric Therapies in Nonalcoholic Steatohepatitis.
    Yeoh A; Wong R; Singal AK
    Clin Liver Dis; 2023 May; 27(2):413-427. PubMed ID: 37024216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequency of Nonalcoholic fatty pancreatic disease in patients with carcinoma pancreas presenting for upper abdominal Endoscopic Ultrasound in a tertiary care center.
    Qureshi S; Memon F; Chisti N; Ghazanfar S; Quraishy MS
    J Pak Med Assoc; 2022 Nov; 72(11):2209-2212. PubMed ID: 37013288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonalcoholic Fatty Liver Disease and Its Complex Relation with Type 2 Diabetes Mellitus-From Prevalence to Diagnostic Approach and Treatment Strategies.
    Diaconu CT; Guja C
    J Clin Med; 2022 Aug; 11(17):. PubMed ID: 36079070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonalcoholic fatty liver disease versus metabolic-associated fatty liver disease: Prevalence, outcomes and implications of a change in name.
    Ng CH; Huang DQ; Nguyen MH
    Clin Mol Hepatol; 2022 Oct; 28(4):790-801. PubMed ID: 35545437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent advances in nonalcholic fatty liver disease.
    Greenfield V; Cheung O; Sanyal AJ
    Curr Opin Gastroenterol; 2008 May; 24(3):320-7. PubMed ID: 18408460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonalcoholic fatty liver disease and the metabolic syndrome.
    Marchesini G; Marzocchi R; Agostini F; Bugianesi E
    Curr Opin Lipidol; 2005 Aug; 16(4):421-7. PubMed ID: 15990591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease Cross Talk.
    Nysather J; Kaya E; Manka P; Gudsoorkar P; Syn WK
    Adv Kidney Dis Health; 2023 Jul; 30(4):315-335. PubMed ID: 37657879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Endoscopic Bariatric and Metabolic Therapies on Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.
    Jirapinyo P; McCarty TR; Dolan RD; Shah R; Thompson CC
    Clin Gastroenterol Hepatol; 2022 Mar; 20(3):511-524.e1. PubMed ID: 33727164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insights into the molecular targets and emerging pharmacotherapeutic interventions for nonalcoholic fatty liver disease.
    Negi CK; Babica P; Bajard L; Bienertova-Vasku J; Tarantino G
    Metabolism; 2022 Jan; 126():154925. PubMed ID: 34740573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Meta-Analysis of Sleep Disorders and Nonalcoholic Fatty Liver Disease: Potential Causality and Symptom Management.
    Yu L; Lin C; Chen X; Teng Y; Zhou S; Liang Y
    Gastroenterol Nurs; 2022 Sep-Oct 01; 45(5):354-363. PubMed ID: 35913418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between the lean nonalcoholic fatty liver disease and risk of incident type 2 diabetes in a healthy population of Northwest China: a retrospective cohort study with a 2-year follow-up period.
    Li N; Xang W; Wu S; Li D; Chang M; Xie C; Zhang MY; Tan H
    Front Endocrinol (Lausanne); 2023; 14():1173757. PubMed ID: 37435491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality of life in patients with nonalcoholic fatty liver disease in combination with essential hypertension considering taste sensitivity to sodium chloride.
    Mashura HY; Hanych TM; Rishko AA
    Wiad Lek; 2016; 69(2 Pt 2):204-7. PubMed ID: 27487534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CKD and nonalcoholic fatty liver disease.
    Targher G; Chonchol MB; Byrne CD
    Am J Kidney Dis; 2014 Oct; 64(4):638-52. PubMed ID: 25085644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dipeptidyl peptidase IV inhibitors: therapeutic potential in nonalcoholic fatty liver disease.
    Yilmaz Y; Atug O; Yonal O; Duman D; Ozdogan O; Imeryuz N; Kalayci C
    Med Sci Monit; 2009 Apr; 15(4):HY1-5. PubMed ID: 19333209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonalcoholic fatty liver disease in the pediatric population: a review.
    Wieckowska A; Feldstein AE
    Curr Opin Pediatr; 2005 Oct; 17(5):636-41. PubMed ID: 16160540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis in Liver Transplantation.
    Carter D; Dieterich DT; Chang C
    Clin Liver Dis; 2018 Feb; 22(1):213-227. PubMed ID: 29128058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is Liver Biopsy Necessary in Patients With Nonalcoholic Fatty Liver Disease?
    Gavril RS; Mihalache L; Arhire L; Grosu C; Gherasim A; Nita O; Oprescu AC; Graur M
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(3):503-7. PubMed ID: 30044567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Harris SE; Poolman TM; Arvaniti A; Cox RD; Gathercole LL; Tomlinson JW
    Am J Physiol Gastrointest Liver Physiol; 2020 Sep; 319(3):G345-G360. PubMed ID: 32755310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.